Â© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
Response of EIF2AK4 (GCN2) to amino acid deficiency	2.75E01	2.43E-01	5.000	ATF3,RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Eukaryotic Translation Termination	2.7E01	2.55E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Eukaryotic Translation Elongation	2.69E01	2.53E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Selenoamino acid metabolism	2.55E01	2.24E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
SRP-dependent cotranslational protein targeting to membrane	2.47E01	2.09E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Nonsense-Mediated Decay (NMD)	2.45E01	2.05E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Eukaryotic Translation Initiation	2.4E01	1.97E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
EIF2 Signaling	2.32E01	1.26E-01	3.500	ATF3,RASD1,RPL10,RPL22,Rpl22l1,RPL23,RPL28,RPL30,RPL31,Rpl34 (includes others),RPL35,RPL35A,RPL36,Rpl36a,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Major pathway of rRNA processing in the nucleolus and cytosol	1.95E01	1.29E-01	4.899	RPL10,RPL22,RPL23,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL36,RPL37A,RPL39,RPL41,RPLP1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
mTOR Signaling	9.5E00	7.48E-02	NaN	DDIT4,PPP2R2D,RASD1,RHOB,RHOC,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Oxidative Phosphorylation	9.04E00	1.07E-01	3.464	COX17,COX6A1,Cox6c,Cox7a2/Cox7a2l2,NDUFA1,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,UQCR11	
Regulation of eIF4 and p70S6K Signaling	7.52E00	7.07E-02	NaN	PPP2R2D,RASD1,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	7.32E00	8.59E-02	3.317	COX6A1,NDUFA1,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,NDUFC2,UCP2,UQCR11	
Coronavirus Pathogenesis Pathway	6.13E00	5.88E-02	-2.887	NFKBIA,RPS12,RPS15,RPS15A,RPS19,RPS21,RPS23,RPS24,RPS26,RPS27,RPS28,RPS29	
Mitochondrial Dysfunction	5.85E00	4.36E-02	-3.873	COX17,COX6A1,Cox6c,Cox7a2/Cox7a2l2,GPX1,NDUFA1,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,TOMM7,UCP2,UQCR11	
Glucocorticoid Receptor Signaling	5.38E00	3.26E-02	NaN	BCL2L1,CDKN1A,DNAH3,DUSP1,FKBP5,FOXO3,HSP90AB1,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,NFKBIA,POLR2K,PTGES3,RASD1,SGK1,SMARCA2	
Sirtuin Signaling Pathway	5.26E00	4.47E-02	-2.111	DUSP6,FOXO3,NDRG1,NDUFA1,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,TOMM6,TOMM7,UCP2	
Granzyme A Signaling	5.13E00	9.46E-02	-2.646	NDUFA1,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4	
RHO GTPase cycle	3.88E00	3.11E-02	3.742	AKAP12,CDC42EP3,CDC42EP4,DOCK9,HSP90AB1,HSPE1,MCF2L,NET1,PKP4,PLEKHG1,RALBP1,RHOB,RHOC,STIP1	
NLR signaling pathways	3.69E00	8.93E-02	2.236	BCL2L1,HSP90AB1,IRAK2,TXNIP,UBE2N	
Estrogen Receptor Signaling	3.18E00	2.93E-02	1.342	CDKN1A,FOXO3,GNG5,HSP90AB1,MMP15,NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,RASD1	
IL-8 Signaling	2.99E00	3.81E-02	2.449	BCL2L1,CCND3,GNG5,IRAK2,NFKBIA,RASD1,RHOB,RHOC	
G alpha (12/13) signalling events	2.97E00	6.25E-02	2.236	GNG5,MCF2L,NET1,RHOB,RHOC	
TP53 Regulates Transcription of Cell Cycle Genes	2.9E00	8.16E-02	2.000	BTG2,CDKN1A,PLK2,RGCC	
PEDF Signaling	2.88E00	5.95E-02	NaN	BCL2L1,FAS,NFKBIA,PNPLA2,RASD1	
HER-2 Signaling in Breast Cancer	2.77E00	3.52E-02	-1.414	CDKN1A,COX17,COX6A1,Cox6c,Cox7a2/Cox7a2l2,FOXO3,NFKBIA,RASD1	
Aryl hydrocarbon receptor signalling	2.73E00	2.86E-01	NaN	HSP90AB1,PTGES3	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	2.71E00	7.27E-02	2.000	FKBP5,HSP90AB1,PTGES3,STIP1	
MAPK6/MAPK4 signaling	2.7E00	5.43E-02	2.000	CCND3,CDC42EP3,FOXO3,HSPB1,SEM1	
RHO GTPases Activate Rhotekin and Rhophilins	2.5E00	2.22E-01	NaN	RHOB,RHOC	
PI3K/AKT Signaling	2.47E00	3.5E-02	1.000	BCL2L1,CDKN1A,FOXO3,HSP90AB1,NFKBIA,PPP2R2D,RASD1	
Semaphorin interactions	2.47E00	6.25E-02	2.000	HSP90AB1,PLXNA2,RHOB,RHOC	
ID1 Signaling Pathway	2.46E00	3.48E-02	0.378	ATF3,BCL2L1,CDKN1A,EGR1,FOXO3,RASD1,RHOC	
Telomerase Signaling	2.4E00	4.63E-02	NaN	CDKN1A,HSP90AB1,PPP2R2D,PTGES3,RASD1	
Interleukin-4 and Interleukin-13 signaling	2.37E00	4.55E-02	2.236	BCL2L1,CDKN1A,CEBPD,FOXO3,S1PR1	
Aryl Hydrocarbon Receptor Signaling	2.34E00	3.77E-02	-1.342	CCND3,CDKN1A,FAS,HSP90AB1,HSPB1,PTGES3	
Glioma Invasiveness Signaling	2.26E00	5.48E-02	NaN	RASD1,RHOB,RHOC,TIMP3	
Chronic Myeloid Leukemia Signaling	2.24E00	2.88E-02	0.707	BCL2L1,CCND3,CDKN1A,FAS,FOXO3,FZD4,HSP90AB1,RASD1	
NGF-stimulated transcription	2.2E00	7.69E-02	NaN	EGR1,SGK1,TRIB1	
Glioblastoma Multiforme Signaling	2.19E00	3.51E-02	1.000	CCND3,CDKN1A,FZD4,RASD1,RHOB,RHOC	
TAK1-dependent IKK and NF-kappa-B activation	2.06E00	6.82E-02	NaN	IRAK2,NFKBIA,UBE2N	
Ferroptosis Signaling Pathway	2.05E00	3.82E-02	-0.447	ANGPTL4,CDKN1A,GCH1,HSPB1,RASD1	
RAR Activation	2.04E00	2.33E-02	1.897	CDKN1A,DUSP1,KLF2,PDE2A,RHOB,RHOC,SMARCA2,SORBS3,STRA6,ZBTB16	
FOXO-mediated transcription of cell cycle genes	1.94E00	1.18E-01	NaN	CDKN1A,FOXO3	
NER (Nucleotide Excision Repair, Enhanced Pathway)	1.93E00	4.4E-02	NaN	POLE4,POLR2K,Polr2l,UBE2N	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	1.92E00	3.55E-02	2.236	CEBPD,CEBPZ,EGR1,FOXO3,MMP15	
Hereditary Breast Cancer Signaling	1.91E00	3.52E-02	NaN	CCND3,CDKN1A,POLR2K,RASD1,SMARCA2	
RHO GTPases activate CIT	1.85E00	1.05E-01	NaN	RHOB,RHOC	
RHO GTPases Activate ROCKs	1.85E00	1.05E-01	NaN	RHOB,RHOC	
FOXO-mediated transcription	1.85E00	1.05E-01	NaN	FOXO3,TXNIP	
Neutrophil Extracellular Trap Signaling Pathway	1.8E00	2.25E-02	3.000	NDUFA2,NDUFA3,NDUFA7,NDUFB2,NDUFB3,NDUFB4,PNPLA2,TOMM6,TOMM7	
Colorectal Cancer Metastasis Signaling	1.78E00	2.58E-02	2.449	BCL2L1,FZD4,GNG5,MMP15,RASD1,RHOB,RHOC	
IL-10 Signaling	1.77E00	3.25E-02	1.342	BCL2L1,CDKN1A,DDIT4,DUSP1,NFKBIA	
CD27 Signaling in Lymphocytes	1.75E00	5.26E-02	NaN	BCL2L1,MAP3K6,NFKBIA	
Sumoylation Pathway	1.75E00	3.88E-02	NaN	FAS,NFKBIA,RHOB,RHOC	
Apoptosis Signaling	1.74E00	3.85E-02	NaN	BCL2L1,FAS,NFKBIA,RASD1	
GADD45 Signaling	1.69E00	5E-02	NaN	CCND3,CDKN1A,FOXO3	
RAF-independent MAPK1/3 activation	1.69E00	8.7E-02	NaN	DUSP1,DUSP6	
Semaphorin Signaling in Neurons	1.68E00	4.92E-02	NaN	PLXNA2,RHOB,RHOC	
CXCR4 Signaling	1.63E00	2.98E-02	2.000	EGR1,GNG5,RASD1,RHOB,RHOC	
Mitochondrial protein import	1.62E00	4.69E-02	NaN	COX17,TOMM6,TOMM7	
MyD88 cascade initiated on plasma membrane	1.62E00	8E-02	NaN	IRAK2,UBE2N	
Prostate Cancer Signaling	1.61E00	3.51E-02	NaN	CDKN1A,HSP90AB1,NFKBIA,RASD1	
Germ Cell-Sertoli Cell Junction Signaling	1.61E00	2.94E-02	NaN	MAP3K6,RASD1,RHOB,RHOC,SORBS1	
Induction of Apoptosis by HIV1	1.6E00	4.62E-02	NaN	BCL2L1,FAS,NFKBIA	
Aldosterone Signaling in Epithelial Cells	1.59E00	2.91E-02	NaN	DUSP1,HSP90AB1,HSPB1,HSPE1,SGK1	
Mitotic Roles of Polo-Like Kinase	1.57E00	4.48E-02	NaN	HSP90AB1,PLK2,PPP2R2D	
ESR-mediated signaling	1.56E00	3.39E-02	2.000	FKBP5,HSP90AB1,POLR2K,PTGES3	
Tetrahydrobiopterin Biosynthesis I	1.54E00	3.33E-01	NaN	GCH1	
Tetrahydrobiopterin Biosynthesis II	1.54E00	3.33E-01	NaN	GCH1	
Sphingosine-1-phosphate Signaling	1.54E00	3.33E-02	NaN	ACER2,RHOB,RHOC,S1PR1	
p38 MAPK Signaling	1.54E00	3.33E-02	1.000	DUSP1,FAS,HSPB1,IRAK2	
RHO GTPases activate PKNs	1.53E00	7.14E-02	NaN	RHOB,RHOC	
Extra-nuclear estrogen signaling	1.47E00	4.11E-02	NaN	FOXO3,GNG5,HSPB1	
Mitophagy	1.47E00	6.67E-02	NaN	TOMM6,TOMM7	
ERK5 Signaling	1.46E00	4.05E-02	NaN	FOXO3,RASD1,SGK1	
MyD88 dependent cascade initiated on endosome	1.45E00	6.45E-02	NaN	IRAK2,UBE2N	
Interleukin-1 family signaling	1.44E00	3.1E-02	2.000	IRAK2,NFKBIA,SEM1,UBE2N	
Hypoxia Signaling in the Cardiovascular System	1.43E00	3.95E-02	NaN	HSP90AB1,NFKBIA,UBE2N	
Antiproliferative Role of Somatostatin Receptor 2	1.42E00	3.9E-02	NaN	CDKN1A,GNG5,RASD1	
Molecular Mechanisms of Cancer	1.41E00	1.64E-02	2.673	ADGRG1,BCL2L1,CCND3,CDKN1A,FAS,FZD4,GNG5,MMP15,NFKBIA,RALBP1,RASD1,RHOB,RHOC,S1PR1	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.39E00	3.8E-02	NaN	BCL2L1,CEBPD,HSP90AB1	
Cardiac Hypertrophy Signaling	1.38E00	2.3E-02	2.236	GNG5,HSPB1,MAP3K6,RASD1,RHOB,RHOC	
Role of PKR in Interferon Induction and Antiviral Response	1.37E00	2.94E-02	0.000	ATF3,FAS,HSP90AB1,NFKBIA	
JAK/STAT Signaling	1.35E00	3.66E-02	NaN	BCL2L1,CDKN1A,RASD1	
BEX2 Signaling Pathway	1.35E00	3.66E-02	NaN	CDKN1A,NFKBIA,PPP2R2D	
Adipogenesis pathway	1.34E00	2.88E-02	-1.000	CEBPD,FZD4,SAP18,TXNIP	
Transmission across Electrical Synapses	1.33E00	2E-01	NaN	GJC1	
FasL/ CD95L signaling	1.33E00	2E-01	NaN	FAS	
Transcriptional regulation of white adipocyte differentiation	1.32E00	3.57E-02	NaN	ANGPTL4,CCND3,CEBPD	
MyD88-independent TLR4 cascade	1.31E00	5.41E-02	NaN	IRAK2,UBE2N	
Cyclins and Cell Cycle Regulation	1.3E00	3.49E-02	NaN	CCND3,CDKN1A,PPP2R2D	
Role of Tissue Factor in Cancer	1.3E00	2.42E-02	1.342	BCL2L1,CCN1,EGR1,PPP2R2D,RASD1	
Cell Cycle Regulation by BTG Family Proteins	1.29E00	5.26E-02	NaN	BTG2,PPP2R2D	
TP53 Regulates Metabolic Genes	1.27E00	3.41E-02	NaN	COX6A1,DDIT4,SESN1	
MAP kinase activation	1.27E00	5.13E-02	NaN	IRAK2,UBE2N	
Inhibition of Matrix Metalloproteases	1.27E00	5.13E-02	NaN	MMP15,TIMP3	
KEAP1-NFE2L2 pathway	1.24E00	3.3E-02	NaN	CDKN1A,SEM1,SESN1	
Ceramide Signaling	1.24E00	3.3E-02	NaN	PPP2R2D,RASD1,S1PR1	
PTEN Signaling	1.23E00	2.65E-02	NaN	BCL2L1,CDKN1A,FOXO3,RASD1	
Autophagy	1.22E00	2.3E-02	1.000	BNIP3,FOXO3,PPP2R2D,SESN1,SLC7A5	
Actin Nucleation by ARP-WASP Complex	1.21E00	3.23E-02	NaN	RASD1,RHOB,RHOC	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	1.21E00	4.76E-02	NaN	IRAK2,UBE2N	
Pyroptosis Signaling Pathway	1.2E00	3.19E-02	NaN	FOXO3,GAS5,TXNIP	
Non-Small Cell Lung Cancer Signaling	1.2E00	3.19E-02	NaN	CCND3,FOXO3,RASD1	
Smooth Muscle Contraction	1.19E00	4.65E-02	NaN	SORBS1,SORBS3	
Oncostatin M Signaling	1.19E00	4.65E-02	NaN	RASD1,TIMP3	
Erythrocytes take up oxygen and release carbon dioxide	1.18E00	1.43E-01	NaN	CA4	
Phosphatidylcholine Biosynthesis I	1.18E00	1.43E-01	NaN	CHKA	
Ceramide Degradation	1.18E00	1.43E-01	NaN	ACER2	
Transcriptional regulation by RUNX3	1.18E00	3.12E-02	NaN	CDKN1A,FOXO3,SEM1	
Small Cell Lung Cancer Signaling	1.18E00	3.12E-02	NaN	BCL2L1,CCND3,NFKBIA	
IL-1 Signaling	1.18E00	3.12E-02	NaN	GNG5,IRAK2,NFKBIA	
Death Receptor Signaling	1.18E00	3.12E-02	NaN	FAS,HSPB1,NFKBIA	
Regulation of mRNA stability by proteins that bind AU-rich elements	1.17E00	4.55E-02	NaN	HSPB1,ZFP36	
TP53 Regulates Transcription of Cell Death Genes	1.17E00	4.55E-02	NaN	FAS,NDRG1	
Cellular response to heat stress	1.17E00	3.09E-02	NaN	HSP90AB1,HSPB1,PTGES3	
Nucleotide Excision Repair	1.17E00	3.09E-02	NaN	POLE4,POLR2K,UBE2N	
p53 Signaling	1.16E00	3.06E-02	NaN	BCL2L1,CDKN1A,FAS	
Senescence Pathway	1.15E00	2.01E-02	0.000	ATF3,CCND3,CDKN1A,FOXO3,PPP2R2D,RASD1	
Glycerophospholipid biosynthesis	1.15E00	3.03E-02	NaN	CHKA,LPIN2,PNPLA2	
VEGF Signaling	1.15E00	3.03E-02	NaN	BCL2L1,FOXO3,RASD1	
p75 NTR receptor-mediated signalling	1.14E00	3E-02	NaN	MCF2L,NET1,NFKBIA	
ATM Signaling	1.14E00	3E-02	NaN	CDKN1A,NFKBIA,PPP2R2D	
DNA damage-induced 14-3-3Ï Signaling	1.14E00	4.35E-02	NaN	BCL2L1,CDKN1A	
HOTAIR Regulatory Pathway	1.13E00	2.45E-02	0.000	CDKN1A,MMP15,NFKBIA,RHOC	
iNOS Signaling	1.12E00	4.26E-02	NaN	IRAK2,NFKBIA	
HMGB1 Signaling	1.1E00	2.4E-02	NaN	PLAT,RASD1,RHOB,RHOC	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	1.1E00	1.95E-02	1.633	FOXO3,MMP15,NFKBIA,RASD1,RHOB,RHOC	
cAMP-mediated signaling	1.1E00	2.12E-02	0.000	AKAP12,DUSP1,DUSP6,PDE2A,S1PR1	
G-Protein Coupled Receptor Signaling	1.1E00	1.56E-02	0.905	ADGRG1,DUSP1,DUSP6,FOXO3,FZD4,GNG5,MAP3K6,NFKBIA,PDE2A,RASD1,S1PR1	
NRF2-mediated Oxidative Stress Response	1.1E00	2.11E-02	NaN	FKBP5,HSP90AB1,MAFF,RASD1,STIP1	
IGF-1 Signaling	1.09E00	2.86E-02	NaN	CCN1,FOXO3,RASD1	
GÎ±q Signaling	1.08E00	2.35E-02	NaN	GNG5,NFKBIA,RHOB,RHOC	
Butyrophilin (BTN) family interactions	1.08E00	1.11E-01	NaN	XDH	
Sphingosine and Sphingosine-1-phosphate Metabolism	1.08E00	1.11E-01	NaN	ACER2	
Phosphatidylethanolamine Biosynthesis II	1.08E00	1.11E-01	NaN	CHKA	
Melanoma Signaling	1.08E00	4E-02	NaN	CDKN1A,RASD1	
MYC Mediated Apoptosis Signaling	1.08E00	4E-02	NaN	BCL2L1,FAS	
PPAR Signaling	1.07E00	2.8E-02	NaN	HSP90AB1,NFKBIA,RASD1	
Serotonin Receptor Signaling	1.07E00	1.71E-02	1.414	FOXO3,GCH1,GNG5,NFKBIA,PNPLA2,RASD1,RHOB,RHOC	
AMPK Signaling	1.07E00	2.07E-02	NaN	CDKN1A,FOXO3,GNG5,PPP2R2D,SMARCA2	
Erythropoietin Signaling Pathway	1.04E00	2.27E-02	0.000	BCL2L1,FOXO3,NFKBIA,RASD1	
Prostanoid Biosynthesis	1.03E00	1E-01	NaN	PTGES3	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	1.03E00	2.68E-02	NaN	POLE4,SEM1,UBE2N	
Tumor Microenvironment Pathway	1.02E00	2.23E-02	0.000	FAS,FOXO3,MMP15,RASD1	
Cardiac Î²-adrenergic Signaling	1.01E00	2.22E-02	NaN	AKAP12,GNG5,PDE2A,PPP2R2D	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	1.01E00	2.63E-02	NaN	NFKBIA,PNPLA2,RASD1	
Amino acids regulate mTORC1	1.01E00	3.64E-02	NaN	CASTOR1,SESN1	
Lymphotoxin Î² Receptor Signaling	1.01E00	3.64E-02	NaN	BCL2L1,NFKBIA	
CDK5 Signaling	1E00	2.61E-02	NaN	EGR1,PPP2R2D,RASD1	
Erythrocytes take up carbon dioxide and release oxygen	9.95E-01	9.09E-02	NaN	CA4	
SUMOylation of immune response proteins	9.95E-01	9.09E-02	NaN	NFKBIA	
Triacylglycerol Biosynthesis	9.93E-01	3.57E-02	NaN	LPIN2,PLPP6	
Bladder Cancer Signaling	9.91E-01	2.59E-02	NaN	CDKN1A,MMP15,RASD1	
Protein Kinase A Signaling	9.83E-01	1.7E-02	0.000	AKAP12,DUSP1,DUSP6,GNG5,NFKBIA,PDE2A,TNS2	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	9.82E-01	1.8E-02	NaN	CEBPD,CEBPZ,FZD4,IRAK2,NFKBIA,RASD1	
MicroRNA Biogenesis Signaling Pathway	9.69E-01	2.14E-02	2.000	HSP90AB1,POLR2K,PTGES3,RASD1	
Role of CHK Proteins in Cell Cycle Checkpoint Control	9.67E-01	3.45E-02	NaN	CDKN1A,PPP2R2D	
Cancer Drug Resistance by Drug Efflux	9.67E-01	3.45E-02	NaN	FOXO3,RASD1	
Cholecystokinin/Gastrin-mediated Signaling	9.67E-01	2.52E-02	NaN	RASD1,RHOB,RHOC	
Reversible hydration of carbon dioxide	9.6E-01	8.33E-02	NaN	CA4	
Tryptophan catabolism	9.6E-01	8.33E-02	NaN	SLC7A5	
Circadian Clock	9.55E-01	3.39E-02	NaN	PER1,USP46	
GNRH Signaling	9.44E-01	2.09E-02	NaN	EGR1,GNG5,MAP3K6,RASD1	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	9.44E-01	2.09E-02	2.000	MAP3K6,NFKBIA,RHOB,RHOC	
Endometrial Cancer Signaling	9.43E-01	3.33E-02	NaN	FOXO3,RASD1	
Hepatic Fibrosis Signaling Pathway	9.35E-01	1.65E-02	1.633	FZD4,IRAK2,KLF9,NFKBIA,RASD1,RHOB,RHOC	
Signaling by Rho Family GTPases	9.32E-01	1.87E-02	2.000	CDC42EP3,CDC42EP4,GNG5,RHOB,RHOC	
Dissolution of Fibrin Clot	9.27E-01	7.69E-02	NaN	PLAT	
Azathioprine ADME	9.27E-01	7.69E-02	NaN	XDH	
Guanosine Nucleotides Degradation III	9.27E-01	7.69E-02	NaN	XDH	
PPARÎ±/RXRÎ± Activation	9.26E-01	2.06E-02	NaN	ADIPOR2,HSP90AB1,NFKBIA,RASD1	
Glioma Signaling	9.2E-01	2.4E-02	NaN	CCND3,CDKN1A,RASD1	
Cytoprotection by HMOX1	9.2E-01	3.23E-02	NaN	COX6A1,TXNIP	
Role of JAK2 in Hormone-like Cytokine Signaling	9.2E-01	3.23E-02	NaN	BCL2L1,CCND3	
TCR signaling	9.12E-01	2.38E-02	NaN	NFKBIA,SEM1,UBE2N	
Pancreatic Adenocarcinoma Signaling	9.12E-01	2.38E-02	NaN	BCL2L1,CDKN1A,RALBP1	
Transcriptional Regulation by MECP2	9.08E-01	3.17E-02	NaN	FKBP5,SGK1	
Protein Ubiquitination Pathway	9.03E-01	1.83E-02	NaN	HSP90AB1,HSPB1,HSPE1,UBE2N,USP46	
TR/RXR Activation	8.97E-01	2.34E-02	NaN	ENO1,KLF9,UCP2	
Pulmonary Healing Signaling Pathway	8.97E-01	2.01E-02	2.000	FZD4,MMP15,NFKBIA,RASD1	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	8.97E-01	7.14E-02	NaN	XDH	
IL-6 Signaling	8.9E-01	2.33E-02	NaN	HSPB1,NFKBIA,RASD1	
Pyridoxal 5'-phosphate Salvage Pathway	8.86E-01	3.08E-02	NaN	MAP3K6,SGK1	
Human Embryonic Stem Cell Pluripotency	8.86E-01	1.99E-02	2.000	FZD4,HSP90AB1,KLF2,RASD1	
ILK Signaling	8.86E-01	1.99E-02	NaN	PPP2R2D,RHOB,RHOC,TMSB10/TMSB4X	
Ephrin Receptor Signaling	8.8E-01	1.98E-02	NaN	GNG5,RASD1,SH2D3C,SORBS1	
Mitotic G1 phase and G1/S transition	8.76E-01	2.29E-02	NaN	CCND3,CDKN1A,SEM1	
fMLP Signaling in Neutrophils	8.76E-01	2.29E-02	NaN	GNG5,NFKBIA,RASD1	
Eicosanoid Signaling	8.7E-01	1.79E-02	2.236	EGR1,GNG5,HSPB1,PNPLA2,RASD1	
Metabolism of nitric oxide: NOS3 activation and regulation	8.69E-01	6.67E-02	NaN	NOSTRIN	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	8.69E-01	6.67E-02	NaN	PTGES3	
Response of EIF2AK1 (HRI) to heme deficiency	8.69E-01	6.67E-02	NaN	ATF3	
HGF Signaling	8.69E-01	2.27E-02	NaN	CDKN1A,MAP3K6,RASD1	
Huntington's Disease Signaling	8.52E-01	1.76E-02	NaN	BCL2L1,GNG5,POLR2K,SEM1,SGK1	
CLEAR Signaling Pathway	8.47E-01	1.75E-02	1.000	BNIP3,CASTOR1,DDIT4,PPP2R2D,RASD1	
Cell Cycle: G1/S Checkpoint Regulation	8.44E-01	2.9E-02	NaN	CCND3,CDKN1A	
SPINK1 General Cancer Pathway	8.44E-01	2.9E-02	NaN	Mt1,RASD1	
Caspase activation via Death Receptors in the presence of ligand	8.43E-01	6.25E-02	NaN	FAS	
FOXO-mediated transcription of cell death genes	8.43E-01	6.25E-02	NaN	FOXO3	
Adenosine Nucleotides Degradation II	8.43E-01	6.25E-02	NaN	XDH	
Cachexia Signaling Pathway	8.35E-01	1.63E-02	2.449	CEBPD,DDIT4,FOXO3,HSP90AB1,PNPLA2,S1PR1	
GM-CSF Signaling	8.34E-01	2.86E-02	NaN	BCL2L1,RASD1	
RHO GTPases Activate Formins	8.21E-01	2.16E-02	NaN	RHOB,RHOC,RPS27	
PIP3 activates AKT signaling	8.15E-01	2.14E-02	NaN	CDKN1A,FOXO3,NR4A1	
CGAS-STING Signaling Pathway	8.15E-01	2.14E-02	NaN	CDKN1A,LRRC8A,NFKBIA	
GÎ±i Signaling	8.15E-01	2.14E-02	NaN	GNG5,RASD1,S1PR1	
Insulin Receptor Signaling	8.15E-01	2.14E-02	NaN	FOXO3,RASD1,SGK1	
ERK/MAPK Signaling	8.11E-01	1.86E-02	NaN	DUSP1,DUSP6,HSPB1,RASD1	
Apelin Endothelial Signaling Pathway	8.08E-01	2.13E-02	NaN	GNG5,KLF2,RASD1	
Xenobiotic Metabolism Signaling	8.08E-01	1.7E-02	NaN	HSP90AB1,MAP3K6,PPP2R2D,PTGES3,RASD1	
Activin Inhibin Signaling Pathway	7.96E-01	1.83E-02	0.000	CDKN1A,FOXO3,NFKBIA,PNPLA2	
C-type lectin receptors (CLRs)	7.83E-01	2.07E-02	NaN	NFKBIA,SEM1,UBE2N	
Angiopoietin Signaling	7.78E-01	2.63E-02	NaN	NFKBIA,RASD1	
Multiple Sclerosis Signaling Pathway	7.76E-01	1.8E-02	0.000	DUSP1,DUSP6,FAS,GAS5	
Metabolism of cofactors	7.74E-01	5.26E-02	NaN	GCH1	
Purine Nucleotides Degradation II (Aerobic)	7.74E-01	5.26E-02	NaN	XDH	
Endocannabinoid Cancer Inhibition Pathway	7.71E-01	2.04E-02	NaN	ATF3,CCND3,CDKN1A	
Thrombin Signaling	7.62E-01	1.78E-02	NaN	GNG5,RASD1,RHOB,RHOC	
NF-ÎºB Activation by Viruses	7.61E-01	2.56E-02	NaN	NFKBIA,RASD1	
Toll-like Receptor Signaling	7.61E-01	2.56E-02	NaN	IRAK2,NFKBIA	
IL-7 Signaling Pathway	7.61E-01	2.56E-02	NaN	CCND3,FOXO3	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	7.52E-01	2.53E-02	NaN	HSP90AB1,NFKBIA	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	7.52E-01	2.53E-02	NaN	NFKBIA,PNPLA2	
Role of BRCA1 in DNA Damage Response	7.44E-01	2.5E-02	NaN	CDKN1A,SMARCA2	
Dopamine Receptor Signaling	7.44E-01	2.5E-02	NaN	GCH1,PPP2R2D	
Relaxin Signaling	7.24E-01	1.94E-02	NaN	GNG5,NFKBIA,PDE2A	
Necroptosis Signaling Pathway	7.24E-01	1.94E-02	NaN	FAS,TOMM6,TOMM7	
Chaperone Mediated Autophagy	7.17E-01	4.55E-02	NaN	HSP90AB1	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	7.12E-01	1.69E-02	0.000	MAP3K6,PPP2R2D,RASD1,SORBS1	
Osteoarthritis Pathway	7.12E-01	1.69E-02	-1.000	DDIT4,FOXO3,FZD4,TIMP3	
Role of MAPK Signaling in the Pathogenesis of Influenza	7.12E-01	2.38E-02	NaN	PNPLA2,RASD1	
LPS-stimulated MAPK Signaling	7.04E-01	2.35E-02	NaN	NFKBIA,RASD1	
BAG2 Signaling Pathway	7.04E-01	2.35E-02	NaN	CDKN1A,SEM1	
Signaling by NODAL	6.99E-01	4.35E-02	NaN	FOXO3	
Vitamin-C Transport	6.99E-01	4.35E-02	NaN	LRRC8A	
Platelet homeostasis	6.96E-01	2.33E-02	NaN	GNG5,PDE2A	
IL-17A Signaling in Fibroblasts	6.89E-01	2.3E-02	NaN	CEBPD,NFKBIA	
Xenobiotic Metabolism AHR Signaling Pathway	6.89E-01	2.3E-02	NaN	HSP90AB1,PTGES3	
Pulmonary Fibrosis Idiopathic Signaling Pathway	6.83E-01	1.53E-02	1.342	EGR1,FOXO3,FZD4,MMP15,RASD1	
Regulation of RUNX1 Expression and Activity	6.83E-01	4.17E-02	NaN	CCND3	
RAS processing	6.83E-01	4.17E-02	NaN	BCL2L1	
Tumoricidal Function of Hepatic Natural Killer Cells	6.83E-01	4.17E-02	NaN	FAS	
Sertoli Cell-Sertoli Cell Junction Signaling	6.82E-01	1.65E-02	2.000	EPB41,MAP3K6,RASD1,SORBS1	
Inhibition of ARE-Mediated mRNA Degradation Pathway	6.81E-01	1.84E-02	NaN	PPP2R2D,SEM1,ZFP36	
Neddylation	6.69E-01	1.63E-02	2.000	CDKN1A,KLHL2,SEM1,ZBTB16	
Cholesterol biosynthesis	6.67E-01	4E-02	NaN	PLPP6	
Insulin processing	6.67E-01	4E-02	NaN	MYRIP	
Regulation of Cellular Mechanics by Calpain Protease	6.67E-01	2.22E-02	NaN	CCND3,RASD1	
Unfolded protein response	6.67E-01	2.22E-02	NaN	CEBPD,CEBPZ	
Factors involved in megakaryocyte development and platelet production	6.6E-01	2.2E-02	NaN	DOCK9,MAFF	
RANK Signaling in Osteoclasts	6.6E-01	2.2E-02	NaN	MAP3K6,NFKBIA	
ABRA Signaling Pathway	6.53E-01	2.17E-02	NaN	EGR1,Tpm4	
Miscellaneous transport and binding events	6.52E-01	3.85E-02	NaN	LRRC8A	
Estrogen-mediated S-phase Entry	6.52E-01	3.85E-02	NaN	CDKN1A	
Ribonucleotide Reductase Signaling Pathway	6.41E-01	1.75E-02	NaN	CDKN1A,FOXO3,SMARCA2	
Effects of PIP2 hydrolysis	6.38E-01	3.7E-02	NaN	DGKH	
ATF4 activates genes in response to endoplasmic reticulum stress	6.38E-01	3.7E-02	NaN	ATF3	
Glycolysis I	6.38E-01	3.7E-02	NaN	ENO1	
Gluconeogenesis I	6.38E-01	3.7E-02	NaN	ENO1	
Apelin Liver Signaling Pathway	6.38E-01	3.7E-02	NaN	FAS	
Class B/2 (Secretin family receptors)	6.26E-01	2.08E-02	NaN	FZD4,GNG5	
Mitochondrial translation	6.26E-01	2.08E-02	NaN	MRPL52,MRPS21	
Glutathione Redox Reactions I	6.24E-01	3.57E-02	NaN	GPX1	
Salvage Pathways of Pyrimidine Ribonucleotides	6.19E-01	2.06E-02	NaN	MAP3K6,SGK1	
Protein folding	6.13E-01	2.04E-02	NaN	GNG5,KIFC3	
DNA Methylation and Transcriptional Repression Signaling	6.13E-01	2.04E-02	NaN	SAP18,TCF15	
UVA-Induced MAPK Signaling	6.13E-01	2.04E-02	NaN	BCL2L1,RASD1	
mRNA Capping	6.11E-01	3.45E-02	NaN	POLR2K	
Processing of Capped Intronless Pre-mRNA	6.11E-01	3.45E-02	NaN	SNRPF	
RAF/MAP kinase cascade	6.07E-01	1.53E-02	2.000	DUSP1,DUSP6,RANBP9,SEM1	
S Phase	6E-01	2E-02	NaN	CDKN1A,SEM1	
Activation of kainate receptors upon glutamate binding	5.98E-01	3.33E-02	NaN	GNG5	
Nucleotide catabolism	5.98E-01	3.33E-02	NaN	XDH	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	5.98E-01	3.33E-02	NaN	FOXO3	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	5.91E-01	1.65E-02	NaN	DUSP1,DUSP6,PLPP6	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	5.91E-01	1.65E-02	NaN	DUSP1,DUSP6,PLPP6	
Beta-catenin independent WNT signaling	5.88E-01	1.96E-02	NaN	FZD4,GNG5	
Integration of energy metabolism	5.82E-01	1.94E-02	NaN	ADIPOR2,GNG5	
Mitotic Prophase	5.82E-01	1.94E-02	NaN	LPIN2,PPP2R2D	
Mouse Embryonic Stem Cell Pluripotency	5.76E-01	1.92E-02	NaN	FZD4,RASD1	
Toll Like Receptor 3 (TLR3) Cascade	5.74E-01	3.12E-02	NaN	UBE2N	
G-protein beta:gamma signalling	5.74E-01	3.12E-02	NaN	GNG5	
Thrombin signalling through proteinase activated receptors (PARs)	5.74E-01	3.12E-02	NaN	GNG5	
RIPK1-mediated regulated necrosis	5.74E-01	3.12E-02	NaN	FAS	
TNFR2 Signaling	5.74E-01	3.12E-02	NaN	NFKBIA	
Dopamine Degradation	5.74E-01	3.12E-02	NaN	Sult1a1	
Cell Cycle Checkpoints	5.72E-01	1.47E-02	2.000	CDKN1A,RPS27,SEM1,UBE2N	
WNK Renal Signaling Pathway	5.65E-01	1.89E-02	NaN	LRRC8A,SGK1	
Activation of Matrix Metalloproteinases	5.63E-01	3.03E-02	NaN	MMP15	
Signal amplification	5.63E-01	3.03E-02	NaN	GNG5	
MAPK targets/ Nuclear events mediated by MAP kinases	5.63E-01	3.03E-02	NaN	DUSP6	
Activation of the pre-replicative complex	5.63E-01	3.03E-02	NaN	POLE4	
Post-translational protein phosphorylation	5.59E-01	1.87E-02	NaN	CCN1,PNPLA2	
ISGylation Signaling Pathway	5.54E-01	1.85E-02	NaN	RPS15,UBE2N	
Triglyceride metabolism	5.52E-01	2.94E-02	NaN	LPIN2	
4-1BB Signaling in T Lymphocytes	5.52E-01	2.94E-02	NaN	NFKBIA	
Î±-Adrenergic Signaling	5.48E-01	1.83E-02	NaN	GNG5,RASD1	
3-phosphoinositide Degradation	5.45E-01	1.55E-02	NaN	DUSP1,DUSP6,PLPP6	
GPVI-mediated activation cascade	5.41E-01	2.86E-02	NaN	RHOB	
Transcriptional Regulation by NPAS4	5.41E-01	2.86E-02	NaN	PLK2	
Coagulation System	5.41E-01	2.86E-02	NaN	PLAT	
Nucleotide Excision Repair Pathway	5.41E-01	2.86E-02	NaN	POLR2K	
Oxytocin Signaling Pathway	5.39E-01	1.42E-02	2.000	GNG5,HSPB1,PNPLA2,RASD1	
Sleep REM Signaling Pathway	5.37E-01	1.8E-02	NaN	EGR1,Mt1	
Regulation of the Epithelial-Mesenchymal Transition Pathway	5.37E-01	1.54E-02	NaN	EGR1,FZD4,RASD1	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	5.31E-01	2.78E-02	NaN	CDKN1A	
FLT3 Signaling	5.31E-01	2.78E-02	NaN	FOXO3	
MIF-mediated Glucocorticoid Regulation	5.31E-01	2.78E-02	NaN	NFKBIA	
Synaptic Long Term Depression	5.25E-01	1.52E-02	NaN	PNPLA2,PPP2R2D,RASD1	
D-myo-inositol-5-phosphate Metabolism	5.25E-01	1.52E-02	NaN	DUSP1,DUSP6,PLPP6	
Processing of Capped Intron-Containing Pre-mRNA	5.23E-01	1.39E-02	2.000	EFTUD2,POLR2K,SAP18,SNRPF	
Antioxidant Action of Vitamin C	5.22E-01	1.75E-02	NaN	NFKBIA,PNPLA2	
Oxytocin in Brain Signaling Pathway	5.21E-01	1.51E-02	NaN	GNG5,PNPLA2,RASD1	
Mitotic G2-G2/M phases	5.21E-01	1.51E-02	NaN	CDKN1A,HSP90AB1,SEM1	
Detoxification of Reactive Oxygen Species	5.21E-01	2.7E-02	NaN	GPX1	
TWEAK Signaling	5.21E-01	2.7E-02	NaN	NFKBIA	
Regulation of Actin-based Motility by Rho	5.17E-01	1.74E-02	NaN	RHOB,RHOC	
IL-13 Signaling Pathway	5.11E-01	1.72E-02	NaN	BCL2L1,DUSP1	
Amyotrophic Lateral Sclerosis Signaling	5.11E-01	1.72E-02	NaN	BCL2L1,GPX1	
NoRC negatively regulates rRNA expression	5.11E-01	2.63E-02	NaN	SAP18	
Resolution of Abasic Sites (AP sites)	5.11E-01	2.63E-02	NaN	POLE4	
Neuregulin Signaling	5.06E-01	1.71E-02	NaN	HSP90AB1,RASD1	
Regulation of TP53 Expression and Degradation	5.02E-01	2.56E-02	NaN	SGK1	
Synthesis of DNA	4.97E-01	1.68E-02	NaN	POLE4,SEM1	
Fc epsilon receptor (FCERI) signaling	4.96E-01	1.46E-02	NaN	NFKBIA,SEM1,UBE2N	
NGF Signaling	4.92E-01	1.67E-02	NaN	MAP3K6,RASD1	
Nitric Oxide Signaling in the Cardiovascular System	4.92E-01	1.67E-02	NaN	HSP90AB1,PDE2A	
3-phosphoinositide Biosynthesis	4.88E-01	1.44E-02	NaN	DUSP1,DUSP6,PLPP6	
HIF1Î± Signaling	4.85E-01	1.44E-02	NaN	CDKN1A,MMP15,RASD1	
RNA Polymerase III Transcription	4.84E-01	2.44E-02	NaN	POLR2K	
S100 Family Signaling Pathway	4.83E-01	1.17E-02	2.333	ADGRG1,CDKN1A,FZD4,IRAK2,MMP15,PLAT,S100A13,S1PR1,Tpm4	
April Mediated Signaling	4.76E-01	2.38E-02	NaN	NFKBIA	
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	4.76E-01	2.38E-02	NaN	Sult1a1	
Integrin Signaling	4.75E-01	1.42E-02	NaN	RASD1,RHOB,RHOC	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	4.73E-01	1.61E-02	NaN	CCN1,PNPLA2	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	4.73E-01	1.61E-02	NaN	FZD4,RASD1	
RHOA Signaling	4.73E-01	1.61E-02	NaN	CDC42EP3,CDC42EP4	
Vasopressin regulates renal water homeostasis via Aquaporins	4.67E-01	2.33E-02	NaN	GNG5	
Aggrephagy	4.67E-01	2.33E-02	NaN	UBE2N	
B Cell Activating Factor Signaling	4.67E-01	2.33E-02	NaN	NFKBIA	
Endocannabinoid Developing Neuron Pathway	4.6E-01	1.57E-02	NaN	GNG5,RASD1	
TBC/RABGAPs	4.59E-01	2.27E-02	NaN	TBC1D14	
MIF Regulation of Innate Immunity	4.59E-01	2.27E-02	NaN	NFKBIA	
Arachidonic acid metabolism	4.51E-01	2.22E-02	NaN	GPX1	
Carboxyterminal post-translational modifications of tubulin	4.51E-01	2.22E-02	NaN	TTLL7	
GPER1 signaling	4.51E-01	2.22E-02	NaN	GNG5	
G Beta Gamma Signaling	4.51E-01	1.55E-02	NaN	GNG5,RASD1	
RHOGDI Signaling	4.48E-01	1.36E-02	NaN	GNG5,RHOB,RHOC	
Cytosolic sensors of pathogen-associated DNA	4.44E-01	2.17E-02	NaN	NFKBIA	
Role of RIG1-like Receptors in Antiviral Innate Immunity	4.44E-01	2.17E-02	NaN	NFKBIA	
tRNA Splicing	4.44E-01	2.17E-02	NaN	PDE2A	
IL-23 Signaling Pathway	4.44E-01	2.17E-02	NaN	NFKBIA	
Response to elevated platelet cytosolic Ca2+	4.39E-01	1.52E-02	NaN	TIMP3,TMSB10/TMSB4X	
Heme signaling	4.36E-01	2.13E-02	NaN	USP46	
nNOS Signaling in Neurons	4.36E-01	2.13E-02	NaN	RASD1	
GÎ±12/13 Signaling	4.35E-01	1.5E-02	NaN	NFKBIA,RASD1	
P2Y Purigenic Receptor Signaling Pathway	4.35E-01	1.5E-02	NaN	GNG5,RASD1	
CCR3 Signaling in Eosinophils	4.31E-01	1.49E-02	NaN	GNG5,RASD1	
NAFLD Signaling Pathway	4.29E-01	1.33E-02	NaN	FOXO3,PNPLA2,PPP2R2D	
G alpha (z) signalling events	4.29E-01	2.08E-02	NaN	GNG5	
DNA Damage Bypass	4.29E-01	2.08E-02	NaN	POLE4	
Retinol Biosynthesis	4.29E-01	2.08E-02	NaN	PNPLA2	
Apelin Muscle Signaling Pathway	4.29E-01	2.08E-02	NaN	GNG5	
STAT3 Pathway	4.27E-01	1.48E-02	NaN	CDKN1A,RASD1	
Nonhomologous End-Joining (NHEJ)	4.22E-01	2.04E-02	NaN	UBE2N	
PFKFB4 Signaling Pathway	4.22E-01	2.04E-02	NaN	XDH	
RAC Signaling	4.19E-01	1.46E-02	NaN	MCF2L,RASD1	
RNA Polymerase I Transcription	4.15E-01	2E-02	NaN	POLR2K	
Assembly of RNA Polymerase II Complex	4.15E-01	2E-02	NaN	POLR2K	
FAT10 Cancer Signaling Pathway	4.15E-01	2E-02	NaN	NFKBIA	
Transcriptional regulation by RUNX2	4.09E-01	1.96E-02	NaN	CDKN1A	
Transcriptional regulation of granulopoiesis	4.09E-01	1.96E-02	NaN	CDKN1A	
TNFR1 Signaling	4.09E-01	1.96E-02	NaN	NFKBIA	
UVC-Induced MAPK Signaling	4.09E-01	1.96E-02	NaN	RASD1	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	4.09E-01	1.96E-02	NaN	CDKN1A	
MSP-RON Signaling in Cancer Cells Pathway	4.07E-01	1.43E-02	NaN	NFKBIA,RASD1	
B-WICH complex positively regulates rRNA expression	4.02E-01	1.92E-02	NaN	POLR2K	
Superpathway of Inositol Phosphate Compounds	4E-01	1.27E-02	NaN	DUSP1,DUSP6,PLPP6	
Xenobiotic Metabolism General Signaling Pathway	3.96E-01	1.4E-02	NaN	MAP3K6,RASD1	
Regulation of Apoptosis	3.96E-01	1.89E-02	NaN	SEM1	
Spliceosomal Cycle	3.96E-01	1.89E-02	NaN	EFTUD2	
G alpha (s) signalling events	3.89E-01	1.38E-02	NaN	GNG5,PDE2A	
Intrinsic Pathway for Apoptosis	3.84E-01	1.82E-02	NaN	BCL2L1	
Metabolism of non-coding RNA	3.84E-01	1.82E-02	NaN	SNRPF	
E3 ubiquitin ligases ubiquitinate target proteins	3.84E-01	1.82E-02	NaN	UBE2N	
CSDE1 Signaling Pathway	3.78E-01	1.79E-02	NaN	CCND3	
DNA Damage/Telomere Stress Induced Senescence	3.78E-01	1.79E-02	NaN	CDKN1A	
Folate Signaling Pathway	3.78E-01	1.79E-02	NaN	CDKN1A	
RNA Polymerase II Transcription	3.75E-01	1.34E-02	NaN	POLR2K,SNRPF	
WNT/SHH Axonal Guidance Signaling Pathway	3.75E-01	1.34E-02	NaN	FZD4,PLXNA2	
Endocannabinoid Neuronal Synapse Pathway	3.75E-01	1.34E-02	NaN	DNAH3,GNG5	
Cardiac Hypertrophy Signaling (Enhanced)	3.73E-01	1.11E-02	2.236	FZD4,GNG5,HSPB1,MAP3K6,PDE2A,RASD1	
Neurexins and neuroligins	3.72E-01	1.75E-02	NaN	EPB41	
CNTF Signaling	3.72E-01	1.75E-02	NaN	RASD1	
Role of IL-17A in Arthritis	3.72E-01	1.75E-02	NaN	NFKBIA	
FAT10 Signaling Pathway	3.72E-01	1.75E-02	NaN	SEM1	
PTEN Regulation	3.71E-01	1.33E-02	NaN	EGR1,SEM1	
NAD Signaling Pathway	3.68E-01	1.32E-02	NaN	POLR2K,SLC7A5	
Signaling by PDGF	3.66E-01	1.72E-02	NaN	PLAT	
Triacylglycerol Degradation	3.66E-01	1.72E-02	NaN	PNPLA2	
Transcriptional regulation by RUNX1	3.65E-01	1.32E-02	NaN	SEM1,SMARCA2	
Docosahexaenoic Acid (DHA) Signaling	3.62E-01	1.2E-02	NaN	BCL2L1,FAS,PNPLA2	
Type II Diabetes Mellitus Signaling	3.61E-01	1.31E-02	NaN	ADIPOR2,NFKBIA	
Metabolism of polyamines	3.61E-01	1.69E-02	NaN	SEM1	
DNA Double Strand Break Response	3.61E-01	1.69E-02	NaN	UBE2N	
Visual phototransduction	3.55E-01	1.67E-02	NaN	STRA6	
NIK-->noncanonical NF-kB signaling	3.55E-01	1.67E-02	NaN	SEM1	
GABA receptor activation	3.55E-01	1.67E-02	NaN	GNG5	
PCP (Planar Cell Polarity) Pathway	3.55E-01	1.67E-02	NaN	FZD4	
eNOS Signaling	3.52E-01	1.28E-02	NaN	HSP90AB1,NOSTRIN	
Collagen degradation	3.5E-01	1.64E-02	NaN	MMP15	
Ovarian Cancer Signaling	3.46E-01	1.27E-02	NaN	FZD4,RASD1	
Epithelial Adherens Junction Signaling	3.46E-01	1.27E-02	NaN	PPP2R2D,RASD1	
Sperm Motility	3.45E-01	1.17E-02	NaN	GNG5,PDE2A,PNPLA2	
IL-2 Signaling	3.45E-01	1.61E-02	NaN	RASD1	
Thrombopoietin Signaling	3.4E-01	1.59E-02	NaN	RASD1	
HEY1 Signaling Pathway	3.36E-01	1.24E-02	NaN	CDKN1A,MMP15	
Mitochondrial biogenesis	3.35E-01	1.56E-02	NaN	USP46	
Melatonin Degradation I	3.35E-01	1.56E-02	NaN	Sult1a1	
Hedgehog ligand biogenesis	3.3E-01	1.54E-02	NaN	SEM1	
Activation of IRF by Cytosolic Pattern Recognition Receptors	3.3E-01	1.54E-02	NaN	NFKBIA	
ERB2-ERBB3 Signaling	3.3E-01	1.54E-02	NaN	RASD1	
Transcriptional Regulatory Network in Embryonic Stem Cells	3.27E-01	1.22E-02	NaN	FZD4,RASD1	
Degradation of the extracellular matrix	3.25E-01	1.52E-02	NaN	MMP15	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	3.25E-01	1.52E-02	NaN	NFKBIA	
WNT/Ca+ pathway	3.25E-01	1.52E-02	NaN	FZD4	
Glutamate Receptor Signaling	3.25E-01	1.52E-02	NaN	GNG5	
CD40 Signaling	3.21E-01	1.49E-02	NaN	NFKBIA	
IL-17A Signaling in Airway Cells	3.21E-01	1.49E-02	NaN	NFKBIA	
Circadian Rhythm Signaling	3.2E-01	1.12E-02	NaN	GNG5,PER1,RASD1	
TNFR2 non-canonical NF-kB pathway	3.16E-01	1.47E-02	NaN	SEM1	
ERBB4 Signaling	3.16E-01	1.47E-02	NaN	RASD1	
Androgen Signaling	3.13E-01	1.18E-02	NaN	GNG5,POLR2K	
Agrin Interactions at Neuromuscular Junction	3.12E-01	1.45E-02	NaN	RASD1	
Role of JAK1 and JAK3 in Î³c Cytokine Signaling	3.12E-01	1.45E-02	NaN	RASD1	
Phospholipases	3.12E-01	1.45E-02	NaN	PNPLA2	
Superpathway of Melatonin Degradation	3.12E-01	1.45E-02	NaN	Sult1a1	
Signaling by the B Cell Receptor (BCR)	3.1E-01	1.18E-02	NaN	NFKBIA,SEM1	
Class I MHC mediated antigen processing and presentation	3.1E-01	1.07E-02	2.000	KLHL2,SEM1,UBE2N,ZBTB16	
TP53 Regulates Transcription of DNA Repair Genes	3.07E-01	1.43E-02	NaN	POLR2K	
ISG15 antiviral mechanism	3.03E-01	1.41E-02	NaN	UBE2N	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	3.03E-01	1.41E-02	NaN	TBC1D4	
Interferon alpha/beta signaling	3.03E-01	1.41E-02	NaN	EGR1	
WNT/Î²-catenin Signaling	3E-01	1.15E-02	NaN	FZD4,PPP2R2D	
Basal Cell Carcinoma Signaling	2.99E-01	1.39E-02	NaN	FZD4	
Ephrin B Signaling	2.99E-01	1.39E-02	NaN	GNG5	
Telomere Maintenance	2.95E-01	1.37E-02	NaN	NOP10	
Senescence-Associated Secretory Phenotype (SASP)	2.95E-01	1.37E-02	NaN	CDKN1A	
Signaling by FGFR2	2.95E-01	1.37E-02	NaN	POLR2K	
Regulation of RUNX2 expression and activity	2.95E-01	1.37E-02	NaN	SEM1	
Serotonin Degradation	2.95E-01	1.37E-02	NaN	Sult1a1	
Opioid Signaling Pathway	2.94E-01	1.07E-02	NaN	GNG5,NFKBIA,RASD1	
Breast Cancer Regulation by Stathmin1	2.91E-01	1.01E-02	2.236	ADGRG1,CCND3,FZD4,GNG5,RASD1,S1PR1	
trans-Golgi Network Vesicle Budding	2.91E-01	1.35E-02	NaN	SORT1	
Cellular response to hypoxia	2.87E-01	1.33E-02	NaN	SEM1	
Tight Junction Signaling	2.84E-01	1.11E-02	NaN	EPB41,PPP2R2D	
Plasma lipoprotein assembly, remodeling, and clearance	2.83E-01	1.32E-02	NaN	ANGPTL4	
GDNF Family Ligand-Receptor Interactions	2.83E-01	1.32E-02	NaN	RASD1	
Macropinocytosis Signaling	2.83E-01	1.32E-02	NaN	RASD1	
Ion channel transport	2.77E-01	1.09E-02	NaN	ATP10A,SGK1	
VDR/RXR Activation	2.75E-01	1.28E-02	NaN	CDKN1A	
Role of WNT/GSK-3Î² Signaling in the Pathogenesis of Influenza	2.75E-01	1.28E-02	NaN	FZD4	
Neurotrophin/TRK Signaling	2.75E-01	1.28E-02	NaN	RASD1	
CREB Signaling in Neurons	2.74E-01	9.88E-03	2.000	ADGRG1,FZD4,GNG5,POLR2K,RASD1,S1PR1	
IL-33 Signaling Pathway	2.72E-01	1.08E-02	NaN	BCL2L1,NFKBIA	
Acute Phase Response Signaling	2.72E-01	1.08E-02	NaN	NFKBIA,RASD1	
Signaling by MET	2.71E-01	1.27E-02	NaN	RANBP9	
IL-3 Signaling	2.71E-01	1.27E-02	NaN	RASD1	
Maturity Onset Diabetes of Young (MODY) Signaling	2.71E-01	1.27E-02	NaN	UCP2	
Renal Cell Carcinoma Signaling	2.71E-01	1.27E-02	NaN	RASD1	
Thyroid Cancer Signaling	2.71E-01	1.27E-02	NaN	RASD1	
Glycosaminoglycan metabolism	2.68E-01	1.25E-02	NaN	B4GALT4	
FXR/RXR Activation	2.68E-01	1.07E-02	NaN	Mt1,TXNIP	
IL-17 Signaling	2.68E-01	1.07E-02	NaN	HSP90AB1,RASD1	
Signaling by NTRK1 (TRKA)	2.64E-01	1.23E-02	NaN	DUSP6	
Activation of anterior HOX genes in hindbrain during early embryogenesis	2.64E-01	1.23E-02	NaN	POLR2K	
Chemokine Signaling	2.64E-01	1.23E-02	NaN	RASD1	
NOD1/2 Signaling Pathway	2.63E-01	1.06E-02	NaN	HSP90AB1,NFKBIA	
Axonal Guidance Signaling	2.62E-01	9.8E-03	NaN	FZD4,GNG5,MMP15,PLXNA2,RASD1	
Macrophage Alternative Activation Signaling Pathway	2.61E-01	1.05E-02	NaN	DUSP1,NFKBIA	
FLT3 Signaling in Hematopoietic Progenitor Cells	2.61E-01	1.22E-02	NaN	RASD1	
Estrogen-Dependent Breast Cancer Signaling	2.61E-01	1.22E-02	NaN	RASD1	
Transport of bile salts and organic acids, metal ions and amine compounds	2.57E-01	1.2E-02	NaN	SLC30A1	
RNA polymerase II transcribes snRNA genes	2.57E-01	1.2E-02	NaN	POLR2K	
Signaling by NOTCH4	2.57E-01	1.2E-02	NaN	SEM1	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	2.56E-01	1.04E-02	NaN	EGR1,RASD1	
Leukocyte Extravasation Signaling	2.54E-01	1.04E-02	NaN	MMP15,TIMP3	
VEGF Family Ligand-Receptor Interactions	2.54E-01	1.19E-02	NaN	RASD1	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	2.52E-01	1.03E-02	NaN	FAS,KLF6	
Endothelin-1 Signaling	2.52E-01	1.03E-02	NaN	PNPLA2,RASD1	
Xenobiotic Metabolism CAR Signaling Pathway	2.52E-01	1.03E-02	NaN	HSP90AB1,PPP2R2D	
Hedgehog 'on' state	2.47E-01	1.16E-02	NaN	SEM1	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	2.47E-01	1.16E-02	NaN	S1PR1	
HIPPO signaling	2.44E-01	1.15E-02	NaN	PPP2R2D	
PDGF Signaling	2.44E-01	1.15E-02	NaN	RASD1	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	2.44E-01	1.15E-02	NaN	FZD4	
Natural Killer Cell Signaling	2.43E-01	1.01E-02	NaN	MAP3K6,RASD1	
TCF dependent signaling in response to WNT	2.41E-01	1.01E-02	NaN	FZD4,SEM1	
Regulation of mitotic cell cycle	2.41E-01	1.14E-02	NaN	SEM1	
RAB GEFs exchange GTP for GDP on RABs	2.38E-01	1.12E-02	NaN	DENND6A	
Immunogenic Cell Death Signaling Pathway	2.35E-01	1.11E-02	NaN	HSP90AB1	
Opioid Signalling	2.35E-01	1.11E-02	NaN	GNG5	
Acute Myeloid Leukemia Signaling	2.32E-01	1.1E-02	NaN	RASD1	
Crosstalk between Dendritic Cells and Natural Killer Cells	2.32E-01	1.1E-02	NaN	FAS	
BMP signaling pathway	2.32E-01	1.1E-02	NaN	RASD1	
Apelin Adipocyte Signaling Pathway	2.32E-01	1.1E-02	NaN	GPX1	
Degradation of beta-catenin by the destruction complex	2.29E-01	1.09E-02	NaN	SEM1	
ERBB Signaling	2.26E-01	1.08E-02	NaN	RASD1	
Gene Silencing by RNA	2.2E-01	1.05E-02	NaN	POLR2K	
Prolactin Signaling	2.2E-01	1.05E-02	NaN	RASD1	
TGF-Î² Signaling	2.17E-01	1.04E-02	NaN	RASD1	
Melanocyte Development and Pigmentation Signaling	2.12E-01	1.02E-02	NaN	RASD1	
ABC-family proteins mediated transport	2.04E-01	9.9E-03	NaN	SEM1	
Potassium Channels	1.99E-01	9.71E-03	NaN	GNG5	
Dilated Cardiomyopathy Signaling Pathway	-0E00	6.67E-03	NaN	PDE2A	
Neurovascular Coupling Signaling Pathway	-0E00	4.31E-03	NaN	PNPLA2	
Wound Healing Signaling Pathway	-0E00	7.94E-03	NaN	NFKBIA,RASD1	
CDX Gastrointestinal Cancer Signaling Pathway	-0E00	4.95E-03	NaN	FZD4	
Macrophage Classical Activation Signaling Pathway	-0E00	5.29E-03	NaN	NFKBIA	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	-0E00	8.2E-03	NaN	FZD4,MMP15	
Synaptic Long Term Potentiation	-0E00	7.58E-03	NaN	RASD1	
Fc Epsilon RI Signaling	-0E00	8.47E-03	NaN	RASD1	
Actin Cytoskeleton Signaling	-0E00	8.2E-03	NaN	RASD1,TMSB10/TMSB4X	
Chaperone Mediated Autophagy Signaling Pathway	-0E00	7.87E-03	-0.447	HSP90AB1,MMP15,NFKBIA,STIP1,TPT1	
Myelination Signaling Pathway	-0E00	9.17E-03	NaN	FZD4,NDRG1,RASD1	
DHCR24 Signaling Pathway	-0E00	7.3E-03	NaN	RASD1	
GABAergic Receptor Signaling Pathway (Enhanced)	-0E00	7.19E-03	NaN	GNG5	
Glutaminergic Receptor Signaling Pathway (Enhanced)	-0E00	6.15E-03	NaN	DGKH,PNPLA2	
NFKBIE Signaling Pathway	-0E00	2.23E-03	NaN	NFKBIA	
Orexin Signaling Pathway	-0E00	4.2E-03	NaN	GNG5	
G alpha (i) signalling events	-0E00	3.88E-03	NaN	GNG5	
Signaling by VEGF	-0E00	9.26E-03	NaN	HSPB1	
Cell surface interactions at the vascular wall	-0E00	4.74E-03	NaN	SLC7A5	
Fcgamma receptor (FCGR) dependent phagocytosis	-0E00	6.37E-03	NaN	HSP90AB1	
Generic Transcription Pathway	-0E00	2.34E-03	NaN	NR4A1	
Mitotic Metaphase and Anaphase	-0E00	8.51E-03	NaN	RPS27,SEM1	
Class A/1 (Rhodopsin-like receptors)	-0E00	3.15E-03	NaN	S1PR1	
L1CAM interactions	-0E00	8E-03	NaN	RANBP9	
Signaling by ROBO receptors	-0E00	8.62E-03	NaN	SEM1	
Regulation of lipid metabolism by PPARalpha	-0E00	8.4E-03	NaN	ANGPTL4	
G alpha (q) signalling events	-0E00	5.75E-03	NaN	GNG5	
Transport of inorganic cations/anions and amino acids/oligopeptides	-0E00	9.62E-03	NaN	SLC7A5	
O-linked glycosylation	-0E00	9.01E-03	NaN	GALNT15	
Hedgehog 'off' state	-0E00	8.85E-03	NaN	SEM1	
Deubiquitination	-0E00	7.6E-03	NaN	NFKBIA,SEM1	
Neutrophil degranulation	-0E00	6.3E-03	NaN	HSP90AB1,NDUFC2,PGLYRP1	
Keratinization	-0E00	4.67E-03	NaN	PKP4	
Mitotic Prometaphase	-0E00	4.93E-03	NaN	RPS27	
DNA Replication Pre-Initiation	-0E00	9.62E-03	NaN	SEM1	
Cargo recognition for clathrin-mediated endocytosis	-0E00	9.35E-03	NaN	FZD4	
Clathrin-mediated endocytosis	-0E00	7.69E-03	NaN	FZD4	
Hepatic Cholestasis	-0E00	8.97E-03	NaN	IRAK2,NFKBIA	
Autism Signaling Pathway	-0E00	6.49E-03	NaN	FZD4,RASD1	
Pancreatic Secretion Signaling Pathway	-0E00	4.05E-03	NaN	CA4	
Protein Sorting Signaling Pathway	-0E00	5.62E-03	NaN	SORT1	
ROBO SLIT Signaling Pathway	-0E00	7.87E-03	NaN	CDKN1A	
BBSome Signaling Pathway	-0E00	6.13E-03	NaN	ADGRG1,FZD4,S1PR1	
Sleep NREM Signaling Pathway	-0E00	8.7E-03	NaN	RASD1	
14-3-3-mediated Signaling	-0E00	7.87E-03	NaN	RASD1	
Role of NFAT in Regulation of the Immune Response	-0E00	2.9E-03	NaN	GNG5,NFKBIA,RASD1	
FcÎ³RIIB Signaling in B Lymphocytes	-0E00	1.88E-03	NaN	RASD1	
CCR5 Signaling in Macrophages	-0E00	4.01E-03	NaN	FAS,GNG5	
Calcium-induced T Lymphocyte Apoptosis	-0E00	2.17E-03	NaN	NR4A1	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	2.35E-03	NaN	FAS	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	4.93E-03	NaN	BCL2L1,PPP2R2D,RASD1	
CD28 Signaling in T Helper Cells	-0E00	1.93E-03	NaN	NFKBIA	
IL-15 Signaling	-0E00	3.8E-03	NaN	BCL2L1,RASD1	
Virus Entry via Endocytic Pathways	-0E00	8.47E-03	NaN	RASD1	
Dendritic Cell Maturation	-0E00	1.68E-03	NaN	NFKBIA	
Reelin Signaling in Neurons	-0E00	7.25E-03	NaN	DNAH3	
Cellular Effects of Sildenafil (Viagra)	-0E00	6.67E-03	NaN	PDE2A	
Factors Promoting Cardiogenesis in Vertebrates	-0E00	6.54E-03	NaN	FZD4	
Renin-Angiotensin Signaling	-0E00	8.26E-03	NaN	RASD1	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	1.97E-03	NaN	NFKBIA	
Corticotropin Releasing Hormone Signaling	-0E00	6.58E-03	NaN	NR4A1	
Type I Diabetes Mellitus Signaling	-0E00	3.93E-03	NaN	FAS,NFKBIA	
Allograft Rejection Signaling	-0E00	2.05E-03	NaN	FAS	
Autoimmune Thyroid Disease Signaling	-0E00	2.18E-03	NaN	FAS	
Graft-versus-Host Disease Signaling	-0E00	2.24E-03	NaN	FAS	
p70S6K Signaling	-0E00	3.45E-03	NaN	PPP2R2D,RASD1	
G Protein Signaling Mediated by Tubby	-0E00	2.14E-03	NaN	GNG5	
Systemic Lupus Erythematosus Signaling	-0E00	3.75E-03	NaN	EFTUD2,RASD1,SNRPF,Snrpg	
FAK Signaling	-0E00	3.84E-03	2.000	ADGRG1,FZD4,RASD1,S1PR1	
PAK Signaling	-0E00	8.55E-03	NaN	RASD1	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	-0E00	8.77E-03	NaN	FZD4,NFKBIA	
Phospholipase C Signaling	-0E00	3.57E-03	NaN	GNG5,RASD1,RHOB,RHOC	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	1.07E-03	NaN	FAS	
Atherosclerosis Signaling	-0E00	7.52E-03	NaN	PNPLA2	
Role of NFAT in Cardiac Hypertrophy	-0E00	8.93E-03	NaN	GNG5,RASD1	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	4.33E-03	NaN	NFKBIA,RASD1	
NUR77 Signaling in T Lymphocytes	-0E00	1.95E-03	NaN	NR4A1	
PKCÎ¸ Signaling in T Lymphocytes	-0E00	5.38E-03	NaN	MAP3K6,NFKBIA,RASD1	
OX40 Signaling Pathway	-0E00	4.18E-03	NaN	BCL2L1,NFKBIA	
PI3K Signaling in B Lymphocytes	-0E00	6.79E-03	NaN	ATF3,FOXO3,NFKBIA,RASD1	
Dopamine-DARPP32 Feedback in cAMP Signaling	-0E00	5.38E-03	NaN	PPP2R2D	
Paxillin Signaling	-0E00	9.35E-03	NaN	RASD1	
Gap Junction Signaling	-0E00	6.15E-03	NaN	GJC1,RASD1	
GÎ±s Signaling	-0E00	7.94E-03	NaN	GNG5	
Agranulocyte Adhesion and Diapedesis	-0E00	4.76E-03	NaN	MMP15	
Granulocyte Adhesion and Diapedesis	-0E00	5.29E-03	NaN	MMP15	
TEC Kinase Signaling	-0E00	6.92E-03	NaN	FAS,GNG5,RHOB,RHOC	
SAPK/JNK Signaling	-0E00	3.98E-03	NaN	GNG5,RASD1	
GABA Receptor Signaling	-0E00	7.58E-03	NaN	GNG5	
IL-4 Signaling	-0E00	6.93E-03	1.000	BCL2L1,FAS,RASD1,TIMP3	
B Cell Receptor Signaling	-0E00	7.89E-03	2.000	BCL2L1,EGR1,MAP3K6,NFKBIA,RASD1	
NF-ÎºB Signaling	-0E00	5.25E-03	NaN	NFKBIA,RASD1,UBE2N	
T Cell Receptor Signaling	-0E00	6.49E-03	-1.000	DUSP6,FOXO3,NFKBIA,RASD1	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	-0E00	8.47E-03	NaN	GNG5	
Gustation Pathway	-0E00	4.95E-03	NaN	LRRC8A	
Phagosome Formation	-0E00	7.18E-03	2.000	ADGRG1,FZD4,PNPLA2,RASD1,S1PR1	
PD-1, PD-L1 cancer immunotherapy pathway	-0E00	9.35E-03	NaN	BCL2L1	
Th1 and Th2 Activation Pathway	-0E00	5.81E-03	NaN	S1PR1	
Th2 Pathway	-0E00	7.3E-03	NaN	S1PR1	
Neuroinflammation Signaling Pathway	-0E00	6.31E-03	NaN	FAS,IRAK2	
Adrenomedullin signaling pathway	-0E00	5.03E-03	NaN	RASD1	
Th17 Activation Pathway	-0E00	4.13E-03	NaN	HSP90AB1,IRAK2	
T Cell Exhaustion Signaling Pathway	-0E00	3.53E-03	NaN	PPP2R2D,RASD1	
Synaptogenesis Signaling Pathway	-0E00	3.17E-03	NaN	RASD1	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	7.78E-03	1.000	FAS,PPP2R2D,RASD1,RHOB,RHOC	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	5.53E-03	1.000	BCL2L1,CCND3,FOXO3,RASD1	
Xenobiotic Metabolism PXR Signaling Pathway	-0E00	5.13E-03	NaN	HSP90AB1	
Semaphorin Neuronal Repulsive Signaling Pathway	-0E00	6.67E-03	NaN	PLXNA2	
Kinetochore Metaphase Signaling Pathway	-0E00	9.09E-03	NaN	DNAH3	
MSP-RON Signaling in Macrophages Pathway	-0E00	8.4E-03	NaN	RASD1	
Calcium Signaling	-0E00	4.55E-03	NaN	Tpm4	
